Login to Your Account

Pharma: Other News To Note

Monday, September 23, 2013
• Otsuka Pharmaceutical Co. Ltd., of Tokyo, and H. Lundbeck A/S, of Copenhagen, Denmark, said the European Medicines Agency’s Committee for Medicinal Products for Human Use recommended marketing authorization for Abilify Maintena (aripiprazole), an intramuscular depot formulation for maintenance treatment of schizophrenia in adults stabilized with oral aripiprazole.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription